[The effect of pro-oxidants on insulin secretion by the isolated rat pancreas]. 1993

V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova

The effect of pro-oxidants (tert-butyl peroxide and FeSO4) on rats perfusing isolated pancreas insulin secretion was studied. Pro-oxidants (10(-4) M) preperfusion during 20 minutes did not change significantly the basal insulin secretion and decreased glucose-stimulated secretion of the one. The content of pancreas TBA-active products increased twice after pro-oxidants effect and ratio of reduced and oxidized glutathiones liberation rates decreased from 2 to 0.5. The disturbance of hormone secretion as a result of decrease of Langerhans islets B-cells reduced glutathione pool is suppose to be one of the mechanisms of hypoinsulinemia development at host's states characterizing with lipids peroxidation activation.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010545 Peroxides A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic (nascent) oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. (From Hawley's Condensed Chemical Dictionary, 11th ed) Peroxide
D005296 Ferrous Compounds Inorganic or organic compounds that contain divalent iron. Compounds, Ferrous
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid

Related Publications

V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
April 1979, Diabetologia,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
February 1980, Endocrinology,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
January 1978, Comptes rendus des seances de la Societe de biologie et de ses filiales,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
December 1979, The Journal of pharmacy and pharmacology,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
August 1971, Prensa medica argentina,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
January 1985, Endocrinology,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
April 1979, The American journal of physiology,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
August 1988, Experimental and clinical endocrinology,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
April 1984, Endocrinology,
V V Ivanov, and I V Lusta, and A V Sitozhevskiĭ, and A V Trofimov, and A A Kozhanova
January 2000, International journal of surgical investigation,
Copied contents to your clipboard!